Chromothripsis under the microscope: a cytogenetic perspective of two cases of AML with catastrophic chromosome rearrangement.

[1]  A. Sivachenko,et al.  Punctuated Evolution of Prostate Cancer Genomes , 2013, Cell.

[2]  J. Korbel,et al.  Criteria for Inference of Chromothripsis in Cancer Genomes , 2013, Cell.

[3]  S. Mai,et al.  Shattered and stitched chromosomes—chromothripsis and chromoanasynthesis—manifestations of a new chromosome crisis? , 2012, Genes, chromosomes & cancer.

[4]  Stephen P. Jackson,et al.  Chromothripsis and cancer: causes and consequences of chromosome shattering , 2012, Nature Reviews Cancer.

[5]  Yongjun Zhao,et al.  Poly‐gene fusion transcripts and chromothripsis in prostate cancer , 2012, Genes, chromosomes & cancer.

[6]  Steven J. M. Jones,et al.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes , 2012, Nature.

[7]  Robert H. Bell,et al.  From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer , 2012, The Journal of pathology.

[8]  Ken Chen,et al.  Clonal architecture of secondary acute myeloid leukemia. , 2012, The New England journal of medicine.

[9]  Ira M. Hall,et al.  Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration , 2012, Nature Genetics.

[10]  D. Zwijnenburg,et al.  Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes , 2012, Nature.

[11]  L. Campbell,et al.  CGH and SNP array using DNA extracted from fixed cytogenetic preparations and long-term refrigerated bone marrow specimens , 2012, Molecular Cytogenetics.

[12]  David T. W. Jones,et al.  Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations , 2012, Cell.

[13]  R. Wilson,et al.  Chromothripsis and Human Disease: Piecing Together the Shattering Process , 2012, Cell.

[14]  Neil J Ganem,et al.  DNA breaks and chromosome pulverization from errors in mitosis , 2012, Nature.

[15]  A. Kohlmann,et al.  TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele , 2012, British journal of haematology.

[16]  Markus J. van Roosmalen,et al.  Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer , 2011, Genome Biology.

[17]  P. Stankiewicz,et al.  Chromosome Catastrophes Involve Replication Mechanisms Generating Complex Genomic Rearrangements , 2011, Cell.

[18]  N. Munshi,et al.  Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients. , 2011, Blood.

[19]  A. Kohlmann,et al.  CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia , 2011, Haematologica.

[20]  Markus J. van Roosmalen,et al.  Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline. , 2011, Human molecular genetics.

[21]  L. Campbell,et al.  A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes. , 2011, Cancer genetics.

[22]  R. Scott Hansen,et al.  Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site , 2011, Nature.

[23]  Xavier Estivill,et al.  Cancer: When catastrophe strikes a cell , 2011, Nature.

[24]  Matthew Meyerson,et al.  Cancer Genomes Evolve by Pulverizing Single Chromosomes , 2011, Cell.

[25]  N. Carter,et al.  Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.

[26]  L. Campbell,et al.  The paradox of 20q11.21 amplification in a subset of cases of myeloid malignancy with chromosome 20 deletion , 2010, Genes, chromosomes & cancer.

[27]  Sarah M. Regan,et al.  Comparison of mitotic cell death by chromosome fragmentation to premature chromosome condensation , 2010, Molecular Cytogenetics.

[28]  R. Hills,et al.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. , 2010, Blood.

[29]  Laura K Conlin,et al.  Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis. , 2010, Human molecular genetics.

[30]  A. Jankowska,et al.  Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome‐wide single nucleotide polymorphism array analysis , 2010, Genes, chromosomes & cancer.

[31]  J. Andrieux,et al.  Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome , 2008, British journal of haematology.

[32]  V. Ugo,et al.  Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions , 2008, Annals of Hematology.

[33]  Owen J. Marshall,et al.  Neocentromeres: new insights into centromere structure, disease development, and karyotype evolution. , 2008, American journal of human genetics.

[34]  L. Campbell,et al.  Dicentric chromosomes and 20q11.2 amplification in MDS/AML with apparent monosomy 20 , 2008, Cytogenetic and Genome Research.

[35]  H. Heng,et al.  Mitotic cell death by chromosome fragmentation. , 2007, Cancer research.

[36]  T. Haferlach,et al.  Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia. , 2007, Blood.

[37]  L. Campbell,et al.  A FISH comparison of variant derivatives of the recurrent dic(17;20) of myelodysplastic syndromes and acute myeloid leukemia: Obligatory retention of genes on 17p and 20q may explain the formation of dicentric chromosomes , 2007, Genes, chromosomes & cancer.

[38]  L. Campbell,et al.  A comparison of two contrasting recurrent isochromosomes 20 found in myelodysplastic syndromes suggests that retention of proximal 20q is a significant factor in myeloid malignancies. , 2005, Cancer genetics and cytogenetics.

[39]  D. Christiansen,et al.  Amplification or duplication of chromosome band 21q22 with multiple copies of the AML1 gene and mutation of the TP53 gene in therapy-related MDS and AML , 2005, Leukemia.

[40]  A. Jauch,et al.  mBAND: a high resolution multicolor banding technique for the detection of complex intrachromosomal aberrations , 2004, Cytogenetic and Genome Research.

[41]  David I. Smith,et al.  Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer , 2003, Genes, chromosomes & cancer.

[42]  B. Swolin,et al.  Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia. , 2003, Cancer genetics and cytogenetics.

[43]  A. Brenner,et al.  WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. , 2001, Cancer research.

[44]  R. Richards.  Fragile and unstable chromosomes in cancer: causes and consequences. , 2001, Trends in genetics : TIG.

[45]  D. Gisselsson,et al.  Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Z. Arbieva,et al.  Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31. , 2000, Blood.

[47]  R. Richards,et al.  Fragile sites still breaking. , 1998, Trends in genetics : TIG.

[48]  M. Höglund,et al.  Fluorescence in situ hybridization analyses of hematologic malignancies reveal frequent cytogenetically unrecognized 12p rearrangements , 1998, Leukemia.

[49]  N. Zhao,et al.  dic(5;17): A recurring abnormality in malignant myeloid disorders associated with mutations of TP53 , 1997, Genes, chromosomes & cancer.

[50]  N. Zhao,et al.  Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[51]  C. Croce,et al.  The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.

[52]  H. Kantarjian,et al.  Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment. , 1995, Blood.

[53]  G. Wahl,et al.  A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. , 1991, Genes & development.

[54]  B. Cohen,et al.  Cancer in relatives of leukemic patients with chromosomal rearrangements at rare (heritable) fragile-site locations in their malignant cells. , 1989, American journal of human genetics.

[55]  G. Sutherland,et al.  Further localization of ETS1 indicates that the chromosomal rearrangement in Ewing sarcoma does not occur at fra(11)(q23) , 1988, Human Genetics.

[56]  G. Sutherland.  Fragile sites on human chromosomes , 1985 .

[57]  J. Yunis,et al.  Constitutive fragile sites and cancer. , 1984, Science.

[58]  R. Bernstein,et al.  Fourth International Workshop on Chromosomes in Leukemia 1982: Abnormalities of chromosome 7 resulting in monosomy 7 or in deletion of the long arm (7q-): review of translocations, breakpoints, and associated abnormalities. , 1984, Cancer genetics and cytogenetics.

[59]  G. Sutherland,et al.  Fragile sites in chromosomes: possible model for the study of spontaneous chromosome breakage. , 1983, Science.

[60]  O. Garson,et al.  Fluorodeoxyuridine synchronization of bone marrow cultures. , 1983, Cancer genetics and cytogenetics.

[61]  K. Sperling,et al.  Mammalian cell fusion , 1974, Chromosoma.

[62]  Robert T. Johnson,et al.  Mammalian cell fusion III. A hela cell inducer of premature chromosome condensation active in cells from a variety of animal species , 1970 .

[63]  A. Sandberg,et al.  Definition and morphologic features of chromosome pulverization: a hypothesis to explain the phenomenon. , 1970, Journal of the National Cancer Institute.

[64]  P. Nowell,et al.  Chromosome preparations of leukocytes cultured from human peripheral blood. , 1960, Experimental cell research.

[65]  B. Mcclintock.  The Behavior in Successive Nuclear Divisions of a Chromosome Broken at Meiosis. , 1939, Proceedings of the National Academy of Sciences of the United States of America.

[66]  B. Dutrillaux,et al.  Common fragile sites: mechanisms of instability revisited. , 2012, Trends in genetics : TIG.

[67]  D. Cooper,et al.  Transient hypermutability, chromothripsis and replication-based mechanisms in the generation of concurrent clustered mutations. , 2012, Mutation research.

[68]  T. Glover,et al.  DNA polymerase α inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes , 2004, Human Genetics.

[69]  M. Seabright.  The use of proteolytic enzymes for the mapping of structural rearrangements in the chromosomes of man , 2004, Chromosoma.

[70]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[71]  G. Dewald,et al.  Acute myeloid leukemia with minimal differentiation. A multiple parameter study. , 1998, American journal of clinical pathology.

[72]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .